We are live on ! Find out more
EC

Eleva Capital Portfolio holdings

AUM $113M
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$343M
AUM Growth
$0
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
97.63%
Holding
24
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.5 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.4 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Materials 81.31%
2 Technology 6.21%
3 Communication Services 6.04%
4 Consumer Discretionary 4.34%
5 Healthcare 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CRH icon
1
CRH
CRH
$55.6B
$279M 81.27%
2,654,974
– –
2025 Q2
4 quarters
AS icon
2
Amer Sports
AS
$16.2B
$9.84M 2.86%
298,802
– –
2025 Q2
4 quarters
NVDA icon
3
NVIDIA
NVDA
$5.78T
$9.07M 2.64%
52,002
– –
2026 Q1
1 quarter
NFLX icon
4
Netflix
NFLX
$286B
$8.38M 2.44%
87,190
– –
2025 Q2
4 quarters
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.25T
$8.04M 2.34%
27,967
– –
2026 Q1
1 quarter
TSM icon
6
TSMC
TSM
$2.5T
$6.51M 1.89%
21,411
– –
2026 Q1
1 quarter
ANET icon
7
Arista Networks
ANET
$272B
$5.77M 1.68%
46,957
– –
2025 Q3
3 quarters
AMZN icon
8
Amazon
AMZN
$2.76T
$3.36M 0.98%
16,155
– –
2026 Q1
1 quarter
TMUS icon
9
T-Mobile US
TMUS
$178B
$3.01M 0.88%
14,347
– –
2026 Q1
1 quarter
HOOD icon
10
Robinhood
HOOD
$101B
$2.19M 0.64%
31,625
– –
2026 Q1
1 quarter
ONON icon
11
On Holding
ONON
$11.1B
$1.71M 0.5%
50,150
– –
2026 Q1
1 quarter
BSX icon
12
Boston Scientific
BSX
$61.1B
$1.67M 0.49%
26,667
– –
2026 Q1
1 quarter
SPOT icon
13
Spotify
SPOT
$100B
$1.32M 0.38%
2,715
– –
2026 Q1
1 quarter
NAMS icon
14
NewAmsterdam Pharma
NAMS
$2.66B
$823K 0.24%
25,721
– –
2026 Q1
1 quarter
CGON icon
15
CG Oncology
CGON
$5.64B
$561K 0.16%
8,289
– –
2026 Q1
1 quarter
ESPR
16
DELISTED
Esperion Therapeutics
ESPR
$502K 0.15%
183,047
– –
2026 Q1
1 quarter
MLYS icon
17
Mineralys Therapeutics
MLYS
$1.94B
$463K 0.13%
17,081
– –
2026 Q1
1 quarter
FENC icon
18
Fennec Pharmaceuticals
FENC
$363M
$327K 0.1%
53,234
– –
2026 Q1
1 quarter
IRON icon
19
Disc Medicine
IRON
$2.37B
$327K 0.1%
5,115
– –
2026 Q1
1 quarter
VRDN icon
20
Viridian Therapeutics
VRDN
$2.06B
$139K 0.04%
7,126
– –
2026 Q1
1 quarter
FCX icon
21
Freeport-McMoran
FCX
$104B
$133K 0.04%
2,258
– –
2026 Q1
1 quarter
ACHR icon
22
Archer Aviation
ACHR
$3.58B
$111K 0.03%
21,534
– –
2026 Q1
1 quarter
EWTX icon
23
Edgewise Therapeutics
EWTX
$4.35B
$55K 0.02%
17,460
– –
2026 Q1
1 quarter
AQST icon
24
Aquestive Therapeutics
AQST
$579M
$11.3K ﹤0.01%
2,720
– –
2026 Q1
1 quarter

Similar funds

ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
IA
Invested Advisors State College, Pennsylvania $113M AUM 23.72% 1-Year Est. Return
MBC
Michael Brady & Co Westlake, Ohio $113M AUM
LAM
Lotus Asset Management Nashville, Tennessee $113M AUM
CPA
Clear Point Advisors Melville, New York $113M AUM 15% 1-Year Est. Return
IIM
IFC & Insurance Marketing Auburn, California $114M AUM
RSEWM
River's Edge Wealth Management Beaver, Pennsylvania $114M AUM
OCM
Objective Capital Management Pepper Pike, Ohio $113M AUM 22.81% 1-Year Est. Return

Eleva Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Eleva Capital held 24 positions worth $343M, unchanged from the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Eleva Capital opened no new positions and made no exits, leaving the 24-position portfolio largely intact.

By sector, the portfolio is most concentrated in Materials at 81% of assets, unchanged from a quarter earlier, followed by Technology and Communication Services.

  • Eleva Capital's ten largest holdings make up 98% of its $343M portfolio in Q2 2026.
  • Eleva Capital opened 0 new positions and closed 0 in Q2 2026.
  • Eleva Capital's portfolio value was unchanged quarter-over-quarter at $343M.

Based on Eleva Capital's 13F filing for Q2 2026, filed 2 Jul 2026.